尿激酶在急性心肌梗死中的应用。
Use of urokinase in acute myocardial infarction.
作者信息
Makolkin V I, Bokarew I N, Buturow V N, Terechow V N, Kuznetzow V A, Seryogina M V, Yarowaya L D
机构信息
First Medical Institute (Setchenow), Moscow, USSR.
出版信息
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):394-7.
PMID:2465237
Abstract
In a prospective study 88 patients with acute MI were treated with urokinase. In comparison to a control group without thrombolytic therapy 50% of the urokinase treated patients showed an improvement as well of coronary sinus blood flow as of parameters of QRST mapping.
摘要
在一项前瞻性研究中，88例急性心肌梗死患者接受了尿激酶治疗。与未接受溶栓治疗的对照组相比，接受尿激酶治疗的患者中有50%在冠状窦血流以及QRST标测参数方面均有改善。
Zotero 插件